Navigation Links
Clinical Conductor CTMS Partners with the Greater Gift Initiative to Donate Vaccines
Date:10/24/2013

Winston-Salem, NC and Rochester, NT (PRWEB) October 24, 2013

The fall conference schedule for the Clinical Trial Industry is in full swing,and Clinical Conductor CTMS, the leading clinical trial management system for research organizations from Bio-Optronics, is actively participating in many events to talk and meet with clinical trial professionals about its family of clinical trial management systems. This year, Clinical Conductor is sharing booth space with the Greater Gift Initiative (GGI) and donating vaccines in honor of conference participants. “We are so appreciative of Clinical Conductor’s support of GGI and their donation of vaccines in honor of visitors to the booth,” says Becca Chase, Executive Director of GGI. “Talking with conference participants in the exhibit hall is a great opportunity to tell the GGI story and ultimately have more clinical trial sites honor their volunteers with the gift of a vaccine to a child in need.” Clinical Conductor donated vaccines on behalf of every attendee at the 2013 Site Solutions Summit held October 11-13 to recognize the Society for Clinical Research Sites (SCRS) for its commitment to helping clinical research sites reach their true potential. In addition to the donations made at the Site Solutions Summit, Clinical Conductor is donating vaccines in honor of participants who visit its booth at CenterWatch’s fall 2013 Forum on Optimizing Clinical Research Performance this week in Las Vegas, Nevada, and at the upcoming MAGI West Clinical Research Conference in Las Vegas on October 27-30. The vaccine donations are being made through the Greater Gift Initiative, whose mission is to advance global health and highlight the greater good of clinical trial participation by gifting a vaccine to a child in honor of every clinical trial volunteer. Vaccines were selected as the gift of choice because they have contributed to the improvement of global health more than any other class of pharmaceuticals. “Our goal is to provide services that allow healthcare professionals to make a meaningful impact,” says Bio-Optronics CEO, Dan Kerpelman. “We felt that the mission of the Greater Gift Initiative is consistent with ours, so donating vaccines to help prevent childhood disease was a natural course of action for our organization.”

About Greater Gift Initiative, Inc.
The mission of Greater Gift Initiative, Inc. is to advance global health and highlight the greater good of clinical trial participation by gifting a vaccine to a child in honor of every clinical trial volunteer, under the motto “Volunteers Advancing Health.” Since 2010, the Greater Gift Initiative has donated over 22,500 vaccines to children in developing countries as a way to give back and thank the volunteers who participate in clinical trials and contribute to the advancement of health worldwide. Learn more at http://www.GreaterGiftInitiative.org.

About Clinical Conductor CTMS
Clinical Conductor CTMS, offered by Bio-Optronics, is the premier family of clinical trial management systems for clinical research professionals. Solving today’s most challenging problems, Clinical Conductor CTMS is the proven research project management tool used by over 1,600 research organizations around the world. Standalone research sites benefit from Clinical Conductor Site CTMS and its versatile tools designed specifically for the needs of sites. Clinical Conductor Enterprise CTMS provides AMCs, SMOs, CROs and provider networks the tools, communication and transparency that is needed for trial success. Clinical Conductor CTMS ensures regulatory compliance, improves study execution speed, improves overall accuracy and increases your profitability, all from the very first day. Our compassionate and expert team of service specialists and engineers are there to support you and continually deliver enhancements, customizations and integrations to meet your specific needs. For more information about Clinical Conductor CTMS please visit our website: http://www.clinicalconductor.com.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11256226.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
2. Positive Clinical Study Results for BSPs HyperQ Technology
3. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
4. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
5. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
6. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
7. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
8. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
9. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
10. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
11. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life Sciences ... development of liquid biopsy tests based on the ... an exclusive license agreement with its first international ... liquid biopsy test for prostate cancer, the Prostate ... . This is the first overseas appointment ...
(Date:2/16/2017)... DUBLIN , Feb. 16, 2017 ... the "Synthetic Biology: Global Markets" report to ... ... synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis ... DNA synthesis and assembly, genome editing, bioinformatics and specialty ...
(Date:2/16/2017)... Feb. 16, 2017   Biostage, Inc. (Nasdaq: ... biotechnology company developing bioengineered organ implants to treat cancers ... trachea, announced today the closing on February 15, 2017 ... of common stock and warrants to purchase 20,000,000 shares ... million. The offering was priced at $0.40 per share ...
(Date:2/16/2017)... DENVER , Feb. 16, 2017 UCHealth ... hospital to utilize LungDirect for pulmonary nodule patient management. ... a nodule, or a spot on the lung, UCHealth ... spent on manual data entry. Stephanie ... been tracking my nodule patients with an Excel spreadsheet, ...
Breaking Biology Technology:
(Date:2/3/2017)... -- Texas Biomedical Research Institute announced that its Board of Trustees ... the Institute,s new President and CEO. Dr. Schlesinger will take ... is currently the Chair of the Department of Microbial Infection ... Biology at Ohio State University. "We are delighted ... of Texas Biomed," said Dr. James O. Rubin , ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to ... and meaningful advances worldwide, The Japan Prize Foundation ... Prize, who have pushed the envelope in their ... and Communication. Three scientists are being recognized with ... achievements that not only contribute to the advancement ...
(Date:1/26/2017)... Jan. 26, 2017  Crossmatch, a leading provider of ... solution aimed at combatting fraud, waste and abuse in ... at the Action on Disaster Relief conference in ... for UN agencies and foreign assistance organizations throughout ... and abuse are a largely unacknowledged problem in the ...
Breaking Biology News(10 mins):